NEW YORK (360Dx) – Danaher said that it expects its first quarter adjusted EPS to exceed the high end of its previous guidance. During its Q4 2017 and full-year 2017 earnings announcement in January, the company said that adjusted EPS for Q1 2018 was anticipated to be in the range of $.90 to $.93.

Danaher President and CEO Thomas Joyce said this week that the firm has started the year strongly from a core revenue and margin perspective. He noted particular strength in the Life Sciences and Diagnostics segment, especially at Cepheid, as main drivers for the new guidance.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.